Algeria vs Switzerland: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Algeria
92.0%
in 2025
Switzerland
92.0%
in 2025
Algeria rank
56th
Switzerland rank
56th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Algeria
- Switzerland
How they compare
Algeria currently reports 92.0% against 92.0% in Switzerland, a difference of 0.0%.
The two have swapped places 3 times across 26 shared years of data; in 2000 it was Algeria ahead.
Algeria ranks 56th and Switzerland ranks 56th of 194 countries.
Across the 3 decades both report, Algeria averaged higher in 2 and Switzerland in 1.
Head to head by decade
| Decade | Algeria | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.5% | 37.9% | 53.6% | Algeria |
| 2010s | 91.8% | 87.2% | 4.6% | Algeria |
| 2020s | 82.2% | 92.8% | 10.7% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Algeria or Switzerland?
- Algeria, at 92.0% against 92.0% in Switzerland as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Algeria and Switzerland?
- 0.0%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Switzerland?
- 26 years are reported by both, from 2000 to 2025.
- How do Algeria and Switzerland rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Algeria ranks 56th and Switzerland ranks 56th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.